Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

David Meininger, Ph.D.

Chief Business Officer at TRIANNI, Inc.

Profile

Dr. Meininger was previously Executive Director, Business Development & Licensing with Merck where he had global responsibility for biologics technologies as a member of the West Coast Innovation Hub. Prior to his transition to business development, he led Protein Science and managed biologic lead generation for immuno-oncology and other programs that progressed to development and onto market. At Amgen, he served on multiple teams that advanced programs from discovery through the clinic. Dr. Meininger completed his postdoc in Protein Engineering at Genentech, received his PhD from UCSD and his MBA from The University of Washington.

Agenda Sessions